Teva Reports First Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Teva Pharma (TEVA) Tops Q1 EPS by 2c, Revenues Miss
May 2, 2019 7:02 AM EDTTeva Pharma (NYSE: TEVA) reported Q1 EPS of $0.60, $0.02 better than the analyst estimate of $0.58. Revenue for the quarter came in at $4.3 billion versus the consensus estimate of $4.38 billion.
Revenues of $4.3 billionGAAP diluted loss per share of $0.10Non-GAAP diluted EPS of $0.60Free cash flow of $360... More